Release Date: October 30, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide an update on the nonaccrual loans and the expected timelines for their resolution? A: Daniel Devorsetz, COO and CIO, explained that some nonaccrual loans were resolved in Q3 through acquisitions or other transactions. A few others are still being worked on and may be resolved in Q4 or the first half of 2025, each with its own specific timeline and strategy.
Q: How did the resolutions of nonaccrual loans in Q3 compare to your expectations? A: Daniel Devorsetz noted that one loan, Nexii, was resolved by selling assets to a high-quality buyer, resulting in debt and equity in the new company. Gerald Michaud, President, added that Evelo's life science assets were consolidated into a holding company, with transactions underway to monetize these assets and pay down Horizon's loan.
Q: Can you discuss the current market environment and pipeline for new deals? A: Daniel Devorsetz stated that the market is improving, with a strong pipeline of quality opportunities. Although some deals have been awarded, they have not yet closed. The expectation is for Q4 to be a growth quarter, with the pipeline at its strongest in a while.
Q: How do you plan to manage the balance sheet and cover the dividend given the current cash levels and NII? A: Daniel Trolio, CFO, explained that they plan capital sources each quarter based on expected funding needs, using cash, debt facilities, and equity. The venture debt portfolio generates prepayments annually, which helps cover distributions over time.
Q: What factors dictate the pace of share sales through the ATM program? A: Daniel Trolio mentioned that the pace is determined by comparing capital sources to expected funding needs each quarter. The volume of trading in the ATM and debt facility capacity also influence the decision.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.